Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-10-27
1984-08-21
Trousof, Natalie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260465D, 424251, 424258, 424263, 424273N, 424273P, 424273R, 424274, 424275, 424285, 424304, 544298, 544318, 544319, 546153, 546294, 546301, 548337, 548346, 548371, 548372, 548375, 548484, 548542, 548543, 548551, 548556, 549 23, 549 28, 549479, 560139, A61K 3122, A61K 31275, A61K 31415, A61K 3144, A61K 31505, C07C 69035, C07C12175, C07D21355
Patent
active
044669810
ABSTRACT:
Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: ##STR1## wherein: R.sup.1 and R.sup.2 are lower alkoxy or lower alkylthio;
REFERENCES:
patent: 3714206 (1973-01-01), Huemer et al.
patent: 4115060 (1978-09-01), Finley et al.
patent: 4181741 (1980-01-01), Bullock
patent: 4229478 (1980-10-01), Jones et al.
patent: 4255405 (1981-03-01), Jones et al.
patent: 4321373 (1982-03-01), Scheler
patent: 4374855 (1983-02-01), Resnick
Chemical Abstracts, vol. 86, Abstract # 55193W, Font et al.
Jones Gordon H.
Venuti Michael C.
Young John M.
Moore Annette M.
Moran Tom M.
Scott Patricia M.
Syntex (U.S.A.) Inc.
Trousof Natalie
LandOfFree
Naphthalene anti-psoriatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalene anti-psoriatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene anti-psoriatic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1937235